How much is a share of GSK worth?
Real time GlaxoSmithKline (GSK) stock price quote, stock graph, news & analysis.
What is the highest ever stock price for GlaxoSmithKline?
Toggle Chart Options. Advanced Charting. 1D 5D 1M 3M 6M YTD 1Y 3Y All Range Dropdown. Volume: 5.11M 65 Day Avg: 5.15M. 99% vs Avg. 46.38 …
When do GSK earnings call?
Apr 07, 2022 · The GlaxoSmithKline PLC stock price gained 1.12% on the last trading day (Thursday, 7th Apr 2022), rising from $45.72 to $46.23. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or …
When will GlaxoSmithKline report its next quarterly earnings?
GlaxoSmithKline (GSK) Outpaces Stock Market Gains: What You Should Know In the latest trading session, GlaxoSmithKline (GSK) closed at $46.23, marking a +1.12% move from the …
Is GSK a good stock to buy?
GlaxoSmithKline plc (ADR) currently has a 4.7% dividend yield. The continuous implementation of new and innovative therapies, favorable mergers and acquisitions (M&A) activities and low occurrence of patent cliffs are all strong drivers of sales growth for 2021.
What is the beta of GSK?
0.37Performance OutlookMarket Cap118.557BBeta (5Y Monthly)0.37PE Ratio (TTM)20.66EPS (TTM)2.26Earnings DateFeb 01, 2017 - Feb 06, 20173 more rows
What companies do GlaxoSmithKline own?
Glaxo WellcomeGlaxo.Burroughs Wellcome.Merger.Beecham.SmithKline.Merger.GSK–Novartis consumer healthcare buy-out.GSK–Pfizer joint venture.More items...
Is GSK listed in the US?
GSK Stock Price | GlaxoSmithKline PLC ADR Stock Quote (U.S.: NYSE) | MarketWatch.
Does GSK pay a dividend?
GSK pays a dividend of $2.20 per share. GSK's annual dividend yield is 4.76%.
Is GSK Pfizer?
Under GSK's separation plan, shareholders will receive stock in the new consumer health group amounting to at least 80% of the 68% stake that GSK currently owns in it. Pfizer owns the remaining 32%.Feb 22, 2022
Is GSK the largest pharmaceutical company?
The Access to Medicine Index (ATMI) published its 2021 report today, with GSK again ranking 1st among 20 of the world's largest pharmaceutical companies.Jan 26, 2021
What drugs does GSK manufacture?
Pharmaceutical productsAdartrel (ropinirole hydrochloride)Advair (salmeterol, fluticasone propionate)Altabax (retapamulin ointment)Altargo (retapamulin)Amerge (naratriptan)Amoxil (amoxicillin)Anectine (suxamethonium chloride)Anoro Ellipta (umeclidinium and vilanterol)More items...
How many drugs does GSK make?
Drugs Associated with GlaxoSmithKline GlaxoSmithKline manufactures, markets and/or distributes more than 66 drugs in the United States.
Is Medicago publicly traded?
Medicago is a publicly-traded biotechnology company focused on the development, production and commercialization of protein-based vaccines and biopharmaceuticals using a proprietary manufacturing system developed from its expertise in the genetic engineering of plants.
How do I buy GlaxoSmithKline stock?
How to buy shares in GlaxoSmithKlineCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Is GSK working on Covid vaccine?
Sanofi and GSK today announce that they intend to submit data from both their booster and Phase 3 efficacy trials as the basis for regulatory applications for a COVID-19 vaccine.Feb 23, 2022
Signals & Forecast
Support, Risk & Stop-loss
There are few to no technical positive signals at the moment. The GlaxoSmithKline PLC stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is GlaxoSmithKline PLC stock A Buy?
GlaxoSmithKline PLC finds support from accumulated volume at $39.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Here's the Next Blockbuster Vaccine Opportunity for Pfizer
The GlaxoSmithKline PLC stock holds several negative signals and despite the positive trend, we believe GlaxoSmithKline PLC will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Why Alector Shares Are Diving Today
Comirnaty, the COVID-19 vaccine marketed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX), should rake in $33.5 billion in sales this year. Pfizer also claims the world's second best-selling vaccine. The company won U.S. regulatory approval for a successor product, Prevnar 20, in immunizing adults earlier this summer.
A large prevalence rate of the virus is going to affect everyone: Doctor
Having dropped from the lofty heights it reached only a few short months ago, Alector (NASDAQ: ALEC) stock was having another bad day on Wednesday. After market hours on Tuesday, Alector announced the departure of two high-level executives.
Pfizer (PFE) Begins Study on RSV Vaccine in Older Adults
Dr. Bhavna Lall, Clinical Assistant Professor, University of Houston College of Medicine, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
GlaxoSmithKline (GSK) Outpaces Stock Market Gains: What You Should Know
Pfizer (PFE) starts a phase III study which will evaluate its respiratory syncytial virus vaccine candidate, RSVpreF in adults aged 60 years and above.
Data is starting to support the need & timeline for a Covid-19 booster vaccine: Virologist
GlaxoSmithKline (GSK) closed at $41.43 in the latest trading session, marking a +0.78% move from the prior day.
What is Goldman Sachs?
Angela Rasmussen, Ph.D., Research Scientist, Vaccine and Infectious Disease Organization at University of Saskatchewan, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
What is consumer and wealth management?
Goldman Sachs Group, Inc. engages in global investment banking, securities, and investment management, which provides financial services. It operates through the following business segments: Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management. The Investment Banking segment serves public and private sector clients around the world and provides financial advisory services, help companies raise capital to strengthen and grow their businesses and provide financing to corporate clients. The Global Markets segment serves its clients who buy and sell financial products, funding and manage risk. The Asset Management segment provides investment services to help clients preserve and grow their financial assets. The Consumer & Wealth Management segment helps clients to achieve their individual financial goals by providing a wealth advisory and banking services. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.
What is the dividend payout ratio for GlaxoSmithKline?
The Consumer & Wealth Management segment helps clients to achieve their individual financial goals by providing a wealth advisory and banking services. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.
How much does GlaxoSmithKline make?
Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 69.23% next year. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. View GlaxoSmithKline's dividend history.
